• AAPL 189.82
  • TSLA 177.46
  • AMZN 184.7
  • MSFT 420.21
  • INTC 31.85
  • EURUSD 1.0875
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. BAYRY.PINK

Bayer AG PK (BAYRY PINK) stock market data APIs

$7.81 -0.02(-0.3%) as of May 17, 2024

Bayer AG PK Financial Data Overview

7.83
7.81
-
7.84
7.76
6.904-14.5879
30 770 M
3 930 M
47 013 M
0.76
0.0038
0.967
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BAYRY',
Type: 'Common Stock',
Name: 'Bayer AG PK',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BYM1C2',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
HomeCategory: NULL,
IsDelisted: false,
}

Bayer AG PK Fundamental Data is available in our Financial Data APIs

  • Net Revenue 47 013 M
  • EBITDA 11 477 M
  • Earnings Per Share -0.86
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bayer AG PK Earnings via APIs

  • Latest Release 2024-04-26
  • EPS/Forecast 0.42

Get Bayer AG PK End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bayer AG PK latest news via APIs

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval Bayer AG (OTC:BAYRY) (OTC:BAYZF) will present detailed results from the Phase...

Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates

This week, Bayer BAYRY released its first-quarter results. J&J JNJ announced that it will acquire a private biotech, Proteologix, which will add the latter’s pipeline candidates in atopic dermatitis...
Do you have any questions?
support@eodhistoricaldata.com